Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/600566 stock hub

SHA/600566 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600566is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

26.4B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600566

In the news

Latest news · SHA/600566

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E15.1

P25 23.5P50 41.3P75 83.2

ROE11.5

P25 -0.9P50 4.1P75 8.8

ROIC42.8

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600566 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

233

Groups with data

Currency

CNY

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	5,026
Employees Change	-204%
Employees Change Percent	-3.9
Enterprise value	CNY 14.7B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE0000018X6
Last refreshed	2026-05-10
Market cap	CNY 26.4B
Price	CNY 28.62
Price currency	CNY
Rev Per Employee	1,174,045.31x
Sector	Healthcare
Sic	3490
Symbol	sha/600566
Website	https://www.jumpcan.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.59%
EV Earnings	8.44x
EV/EBIT	8.05x
EV/EBITDA	6.85x
EV/FCF	14.37x
EV/Sales	2.49x
FCF yield	3.87%
P/B ratio	1.76x
P/E ratio	15.14x
P/S ratio	4.47x
PE Ratio10 Y	15.86x
PE Ratio3 Y	11.64x
PE Ratio5 Y	11.66x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	30.89%
EBITDA Margin	36.17%
FCF margin	17.3%
Gross margin	80.04%
Gross Profit	CNY 4.7B
Gross Profit Growth	-15.4%
Gross Profit Growth Q	-15.85%
Gross Profit Growth3 Y	-14.62%
Gross Profit Growth5 Y	-1.01%
Net Income	CNY 1.7B
Net Income Growth	-18.29%
Net Income Growth Q	-9.13%
Net Income Growth Years	0%
Net Income Growth3 Y	-8.47%
Net Income Growth5 Y	6.77%
Pretax Margin	35.96%
Profit Margin	29.45%
Profit Per Employee	CNY 345,734
Profitable Years	28
ROA	6.3
Roa5y	9.05
ROCE	11.97
ROE	11.5
Roe5y	18.92
ROIC	42.79
Roic5y	49.54

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	4.97%
Cagr1y	15.15%
Cagr3y	1.26%
Cagr5y	13.03%
Div CAGR10	17.98%
Div CAGR3	45.39%
Div CAGR5	11.19%
EPS Growth	-18.5
EPS Growth Q	-8.33
EPS Growth Years	0
EPS Growth3 Y	-8.75
EPS Growth5 Y	5.24
FCF Growth	-32.76%
FCF Growth Q	-10.63%
FCF Growth3 Y	-27.98%
FCF Growth5 Y	-6.17%
OCF Growth	-21.26%
OCF Growth Q	10.89%
OCF Growth10 Y	5.51%
OCF Growth3 Y	-23.91%
OCF Growth5 Y	-6.58%
Revenue Growth	-17.35x
Revenue Growth Q	-20.84x
Revenue Growth Years	0x
Revenue Growth3 Y	-13.79x
Revenue Growth5 Y	-0.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.33
Assets	CNY 17.8B
Cash	CNY 12.6B
Current Assets	CNY 14.2B
Current Liabilities	CNY 2.6B
Debt	CNY 838.5M
Debt EBITDA	CNY 0.39
Debt Equity	CNY 0.06
Debt FCF	CNY 0.82
Equity	CNY 15B
Liabilities	CNY 2.8B
Long Term Assets	CNY 3.6B
Long Term Liabilities	CNY 217.4M
Net Cash	CNY 11.7B
Net Cash By Market Cap	CNY 44.5
Net Cash Growth	-1.28%
Net Debt EBITDA	CNY -5.5
Net Debt Equity	CNY -0.78
Net Debt FCF	CNY -11.5
Tangible Book Value	CNY 14.4B
Tangible Book Value Per Share	CNY 15.87
WACC	5.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.46
Inventory Turnover	2.85
Net Working Capital	CNY -146.2M
Quick ratio	5.29
Working Capital	CNY 11.6B
Working Capital Turnover	CNY 0.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.25%
Dividend Growth	60.77%
Dividend Growth Years	4%
Dividend per share	CNY 2.09
Dividend Years	11
Dividend Yield	7.3%
Ex Div Date	2025-06-30
Last Dividend	CNY 2.09
Payout Frequency	Annual
Payout Ratio	111.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	62.39%
1Y total return	15.14%
200-day SMA	26.44
3Y total return	3.82%
50-day SMA	26.68
50-day SMA vs 200-day SMA	50over200
5Y total return	84.47%
All Time High	54.97
All Time High Change	-47.94%
All Time High Date	2018-05-29
All Time Low	14.37
All Time Low Change	99.16%
All Time Low Date	2021-08-20
ATR	0.73
Beta	0.19
Beta1y	0.17
Beta2y	0.41
Ch YTD	8.82
High	28.94
High52	29.3
High52 Date	2025-06-27
High52ch	-2.32%
Low	28.28
Low52	24.12
Low52 Date	2026-04-13
Low52ch	18.66%
Ma50ch	7.27%
Price vs 200-day SMA	8.24%
RSI	70.26
RSI Monthly	52.57
RSI Weekly	57.16
Sharpe ratio	0.66x
Sortino ratio	1.22
Total Return	7.05%
Tr YTD	8.82
Tr1m	9.61%
Tr1w	2.73%
Tr3m	6.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 1.8B
Operating Income Growth	-11.21
Operating Income Growth Q	-21.24
Operating Income Growth3 Y	-8.08
Operating Income Growth5 Y	6.54
Operating margin	30.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	345,863,625%
Net Borrowing	710,157,651
Shares Insiders	5.13%
Shares Institutions	7.27%
Shares Out	921,662,260
Shares Qo Q	-1.29%
Shares Yo Y	0.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 1B
Average Volume	6,314,209.3x
Bv Per Share	16.48
CAPEX	CNY -264M
Ch10y	17.01
Ch1m	9.61
Ch1w	2.73
Ch1y	6.83
Ch3m	6.79
Ch3y	-9.92
Ch5y	51.83
Ch6m	8.95
Change	0.92%
Change From Open	0.21
Close	28.36
Days Gap	0.71
Depreciation Amortization	311,389,817
Dollar Volume	200,176,322.2
Earnings Date	2026-04-24
EBIT	CNY 1.8B
EBITDA	CNY 2.1B
EPS	CNY 1.89
F Score	5
FCF	CNY 1B
FCF EV Yield	6.96x
FCF Per Share	CNY 1.11
Financing CF	-1,253,192,974
Fiscal Year End	December
Goodwill	167,303,834
Graham Number	26.47747
Graham Upside	-7.49
Income Tax	CNY 385.7M
Investing CF	-3,517,972,083
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Lynch Fair Value	CNY 12.8
Lynch Upside	-55.26
Ma150	26.4
Ma150ch	8.41%
Ma20	26.09
Ma20ch	9.69%
Net CF	-3,486,455,894
Next Earnings Date	2026-08-24
Open	28.56
P FCF Ratio	25.84
P OCF Ratio	20.53
Payment Date	2025-06-30
Position In Range	51.52
Ppne	2,375,719,552
Price Date	2026-05-08
Price EBITDA	CNY 12.36
Ptbv Ratio	1.83
Relative Volume	1.12x
Revenue	5,900,751,711x
Tax By Revenue	6.54x
Tax Rate	18.18%
Tr6m	8.95%
Volume	6,994,281

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600566 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+7.3%

$2.09 annual per share

Payout ratio

+111.2%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+11.2%

4 consecutive years of growth

Total shareholder yield

+7.1%

Next ex-dividend date: 2025-06-30

Performance

SHA/600566 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600566?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.3%

Share of float held by funds and institutions

Insider ownership

+5.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.3%

Negative means the company is buying back shares.

Technical

SHA/600566 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

70.3

Above 70: short-term overbought

Price vs 200-day MA

+8.2%

50/200-day relationship not available

Beta (5Y)

0.19

Less volatile than the market

Sharpe ratio

0.66

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600566

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600566 stock rating?

sha/600566 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600566 analysis?

The full report lives at /stocks/sha/600566/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600566?

The latest report frames sha/600566 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600566 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.